Figure 6
The effect of 113āĪ¼M I3C, 2.30āĪ¼M sorafenib and their combination on the levels of NOX-1.
Each point is the meanāĀ±āSD of 3āindependent experiments. a or b: Significantly different from the control or sorafenib group, respectively, pā<ā0.05 using ANOVA followed by TukeyāKramer as post-hoc test.
